Company Encyclopedia
View More
name
Agilent Tech
A.US
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
755.08 B
A.USMarket value -Rank by Market Cap -/-

Financial Score

20/12/2025 Update
B
Life Sciences Tools and ServicesIndustry
Industry Ranking3/61
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.62%A
    • Profit Margin18.75%A
    • Gross Margin52.43%B
  • Growth ScoreC
    • Revenue YoY6.73%C
    • Net Profit YoY1.09%C
    • Total Assets YoY7.44%B
    • Net Assets YoY14.29%A
  • Cash ScoreC
    • Cash Flow Margin533.23%C
    • OCF YoY6.73%C
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreC
    • Gearing Ratio47.03%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    13:07 ET Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing

    Wasatch BioLabs (WBL) announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation Sequencing (dTMS) platform. The collaboration combines Agilent's enrichment chemistries with WBL's native-read workflow, enhancing targeted multi-omic analysis for research and clinical studies. This partnership aims to deliver high-quality NGS data, improve turnaround times, and accelerate the development of cost-efficient native-read assays. The service will remain in early access through Q1 2026, with early adopters shaping future enhancements.

    prnewswire·
    US
    A
    +0.25%
    prnewswire·
    US
    A
    +0.25%

    Booking Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

    Booking Holdings Inc. shares fell 1.76% to $5,340.98 on Wednesday, underperforming compared to some competitors. The S&P 500 Index and Dow Jones Industrial Average also declined. This marks the second consecutive day of losses for Booking Holdings, which is 8.54% below its 52-week high. Competitors showed mixed results: Expedia fell 0.77%, Trip.com rose 1.35%, and Tripadvisor fell 3.21%.

    Dow Jones·
    US
    BKNG
    +0.90%
    Dow Jones·
    US
    BKNG
    +0.90%

    HCA Healthcare Inc. Stock Underperforms Tuesday When Compared To Competitors

    HCA Healthcare Inc.'s stock fell 1.51% to $469.79 on Tuesday, underperforming compared to some competitors. This marked the second consecutive day of losses for HCA, closing 9.66% below its 52-week high. The trading volume matched its 50-day average. In contrast, Community Health Systems Inc. rose 0.93%, while Tenet Healthcare Corp. fell 0.22%. The overall market also saw declines, with the S&P 500 and Dow Jones Industrial Average both falling.

    Dow Jones·
    US
    HCA
    +1.38%
    Dow Jones·
    US
    HCA
    +1.38%

    Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference | A Stock News

    Agilent Technologies Inc. announced that CEO Padraig McDonnell and CFO Adam Elinoff will present at the 44th Annual J.P. Morgan Healthcare Conference on Jan. 13, 2026. A live audio webcast and replay will be available on Agilent’s Investor Relations website. Agilent is a global leader in analytical and clinical laboratory technologies, with $6.95 billion in revenue in fiscal year 2025 and approximately 18,000 employees worldwide.

    StockTitan·
    US
    A
    +0.25%
    StockTitan·
    US
    A
    +0.25%

    Agilent Technologies (NYSE:A) Upgraded at Barclays

    Barclays upgraded Agilent Technologies to "overweight" with a $165 price target, indicating a 16.66% potential upside. Other analysts also issued positive ratings, with target prices ranging from $162 to $180. Agilent's stock performance shows a 52-week range of $96.43 to $160.27, and recent earnings beat estimates. Insider trading includes significant stock sales by the CEO and VP. Hedge funds have adjusted their positions, with notable increases in holdings.

    Market Beat·
    US
    A
    +0.25%
    Market Beat·
    US
    A
    +0.25%
    Posts
    View More

    $Tesla(TSLA.US) $iShares Bitcoin Trust ETF(IBIT.US) Yes, this data is completely authentic, just released by ADP at 8:15 AM ET today (December 3, 2025). The confirmed figures are as follows (identical...

    • 0
    © 2025 Longbridge｜Disclaimer